eli lilly glp-1 analog RO OFFERS LILLY'S FOUNDAYO™, THE NEWEST INNOVATION GLP-1 brands: Eli Lilly is

consumers should verify current status directly through LegitScript before enrollment App available: Yes - iOS App Store and Google Play Support: 24/7 access to support team (brand-stated) Contact: [email protected] Governing law: State of Iowa (per Terms of Use) "USA Made" claim: Appears on official lander

2 DPP-4 inhibitors are one of the two incretin-based medication classes

doi: 10.1016/j.clinre.2021.101794 88 SterniniCAnselmiLRozengurtE

Options include once-weekly dulaglutide or once-daily liraglutide, though these medications also carry gastrointestinal side effect risks

COMMON INJURIES FROM DEFECTIVE PRODUCTS Products may be defective in many different ways resulting in various types of catastrophic harm to consumers

Contact your healthcare provider within 24 hours if you experience: Persistent vomiting (more than 24 hours) preventing adequate fluid intake Severe diarrhea (more than 6 episodes daily) lasting beyond 48 hours Inability to keep down fluids despite anti-nausea measures Weight loss exceeding 23 pounds in 24 hours (likely fluid loss) Markedly reduced urine output with dark, concentrated urine New or worsening dizziness affecting daily activities or causing falls Blood glucose readings consistently above target despite usual management Seek immediate medical attention (emergency department or call 911) for: Severe, persistent abdominal pain (may indicate pancreatitis or gallbladder disease, which are labeled risks of GLP-1 medications requiring immediate evaluation and drug discontinuation) [1] Severe dizziness or fainting episodes Rapid or irregular heartbeat with chest discomfort Confusion, disorientation, or altered mental status Inability to urinate for 12+ hours Signs of acute kidney injury (decreased urine output, swelling, severe fatigue) Symptoms of hyperglycemic emergencies in diabetes patients (excessive thirst, frequent urination, fatigue, fruity breath) Patients with pre-existing kidney disease, heart failure, or those taking multiple medications affecting fluid balance should maintain closer communication with their healthcare team